Skip to main content

Site notifications

AusPAR: Lenvatinib (as mesilate)

Australian Public Assessment Report
Device/Product Name
Lenvima
Active ingredients
Lenvatinib (as mesilate)
AusPAR Date
Published
Submission Number
PM-2019-02448-1-4
Submission Type
Extension of indications
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site